Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-01-22 @ 10:43 AM
Study NCT ID:
NCT04579666
Status:
TERMINATED
Last Update Posted:
2025-04-24
First Post:
2020-09-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-22
First Submit QC Date:
None
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-27
Results First Submit QC Date:
None
Results First Post Date:
2025-04-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-24
Last Update Post Date Type:
ACTUAL